Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$303.69
pos +0.00
+0.00%
Today's Range: 299.76 - 306.45 | BIIB Avg Daily Volume: 2,346,100
Last Update: 08/28/15 - 4:00 PM EDT
Volume: 0
YTD Performance: -10.53%
Open: $0.00
Previous Close: $304.49
52 Week Range: $265.00 - $480.18
Oustanding Shares: 235,169,225
Market Cap: 71,606,677,320
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 10 10 10
Moderate Buy 2 2 2 2
Hold 9 9 8 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.89 1.93 1.88 1.82
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 20.56
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
20.56 20.60 25.43
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-24.10% -11.00% 107.40%
GROWTH 12 Mo 3 Yr CAGR
Revenue 46.50 0.92 0.24
Net Income 57.90 1.32 0.32
EPS 58.30 1.44 0.34
Earnings for BIIB:
EBITDA 3.41B
Revenue 8.51B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $3.92 $4.01 $15.92 $17.71
Number of Analysts 20 20 21 21
High Estimate $4.61 $4.54 $16.86 $21.48
Low Estimate $3.67 $3.76 $15.50 $16.20
Prior Year $3.79 $4.08 $13.79 $15.92
Growth Rate (Year over Year) 3.50% -1.79% 15.44% 11.22%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Aug 27, 2015 | 11:25 AM EDT

Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.

By

Chris Versace and Lenore Hawkins

 | Aug 26, 2015 | 2:00 PM EDT

We saw this coming, but there's more to the recent turmoil than China.

By

Bret Jensen

 | Aug 24, 2015 | 9:00 AM EDT

It could be time to deploy some of your dry powder.

By

Dan Fitzpatrick

 | Aug 7, 2015 | 3:56 PM EDT

It looks like how Dow transportation average did before it imploded.

By

Helene Meisler

 | Aug 4, 2015 | 8:00 PM EDT

Disney could become the latest have to join the have-nots.

By

Jim Cramer

 | Aug 4, 2015 | 3:40 PM EDT

There's no such thing as a 'safe harbor' right now on Wall Street.

By

Jim Cramer

 | Aug 1, 2015 | 9:00 AM EDT

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

By

David Katz

 | Jul 30, 2015 | 11:00 AM EDT

Drugmaker has one of the best showings of earnings season.

By

David Katz

 | Jul 30, 2015 | 8:30 AM EDT

Drugmaker has one of the best showings of earnings season.

By

James "Rev Shark" DePorre

 | Jul 29, 2015 | 4:05 PM EDT

Oil- and commodity-related shares perform well.

Infant formula maker Mead Johnson Nutrition (MJN) saw two insider buys totaling 15,000 sha...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.